Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06290570 · ClinicalTrials.gov registry record
A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's
A clinical trial of Hypertrophic Cardiomyopathy, sponsored by Mayo Clinic.
- Active
- Registry status
- 183
- Enrollment target
- 1
- Study location
NCT06290570: Active study of Hypertrophic Cardiomyopathy, sponsored by Mayo Clinic.
NCT06290570 is a study of Hypertrophic Cardiomyopathy that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 183 participants, below the 1,333-participant average among 10 other Hypertrophic Cardiomyopathy trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06290570, a study of Hypertrophic Cardiomyopathy, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 183 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the AI-ECG algorithm for HCM in detecting HCM and in differentiating it from athlete's using not only the standard 12-lead ECG, but also ECGs obtained with the Apple Watch and Alivecor KardiaMobile devices.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST 12-Lead ECG
- DIAGNOSTIC_TEST Apple Smart Watch Single Lead ECG
- DIAGNOSTIC_TEST AliveCor KardiaMobile 6-Lead ECG
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2024-05-07 |
| Est. Completion | 2026-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06290570
The ClinicalTrials.gov registry entry for NCT06290570 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,333-participant average among 10 other Hypertrophic Cardiomyopathy trials with a reported enrollment target (86% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertrophic Cardiomyopathy appearing as the primary indexed condition, and to 3 interventions - of which 12-Lead ECG is the first listed.
NCT06290570 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06290570 about?
NCT06290570 is a clinical study titled "A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's". The purpose of this study is to evaluate the AI-ECG algorithm for HCM in detecting HCM and in differentiating it from athlete's using not only the standard 12-lead ECG, but also ECGs obtained with the Apple Watch and Alivecor KardiaMobile devices.
What is the current status of trial NCT06290570?
This trial is currently active not recruiting. The enrollment target is 183 participants. The study started on 2024-05-07. Estimated completion is 2026-12.
What conditions does trial NCT06290570 study?
This clinical trial studies the following conditions: Hypertrophic Cardiomyopathy.
What interventions are being tested in trial NCT06290570?
The interventions under investigation include: 12-Lead ECG (DIAGNOSTIC_TEST), Apple Smart Watch Single Lead ECG (DIAGNOSTIC_TEST), AliveCor KardiaMobile 6-Lead ECG (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06290570?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06290570 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertrophic Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cardiovascular Multimodality Imaging Study
RECRUITING
-
VIZ ACCESS HCM - Multi-Site Registry
RECRUITING
-
Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
RECRUITING · NA
-
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
RECRUITING · Phase 1
-
Mavacamten Pregnancy Surveillance Program
RECRUITING
-
Pediatric Cardiomyopathy Mutation Analysis
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.